Variant report
Variant | esv3415754 |
---|---|
Chromosome Location | chr3:161461908-161463856 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77577064 | chr3:161463500-161463501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534689325 | chr3:161463534-161463535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531242297 | chr3:161463544-161463545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73014592 | chr3:161463564-161463565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187959625 | chr3:161463568-161463569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs514683 | chr3:161463625-161463626 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs552337708 | chr3:161463653-161463654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566234143 | chr3:161463669-161463670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181011593 | chr3:161463680-161463681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79472201 | chr3:161463691-161463692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376896373 | chr3:161463698-161463699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576667346 | chr3:161463729-161463730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183939766 | chr3:161463787-161463788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188663022 | chr3:161463804-161463805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537373512 | chr3:161463810-161463811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540429160 | chr3:161463813-161463814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370862237 | chr3:161463831-161463832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577000369 | chr3:161463854-161463855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:161463400-161464600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:161463600-161465200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr3:161463600-161465200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr3:161463600-161465200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |